Live Breaking News & Updates on Lifesci Partners Corporate Access Event

Stay updated with breaking news from Lifesci partners corporate access event. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genenta to Take Part in Gene Therapy Panel and Two Virtual Investor Events in January 2021


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Genenta to Take Part in Gene Therapy Panel and Two Virtual Investor Events in January 2021
Genenta ScienceJanuary 5, 2021 GMT
MILAN, Italy and NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer (Temferon™), announced that Prof. Luigi Naldini, Co-Founder and Chairman of its Executive Scientific Board, will take part in a gene therapy panel discussion at the LifeSci Partners 10th Annual Healthcare Corporate Access Event which is being held virtually from January 6-8 and 11-14. ....

New York , United States , Pierluigi Paracchi , Luigi Naldini , Stefania Mazzoleni , Mary Ann Chang , John Carroll , Executive Scientific Board , Lifesci Partners , Annual Healthcare Corporate Access Event , Standard Time , Lifesci Partners Corporate Access Event , Chief Executive Officer Pierluigi Paracchi , Endpoints News , Glioblastoma Multiforme , Sci Advisors , Investor Contact , Ann Chang , Stem Cell Research , Health Care Industry , Gene Therapy , Cell Biology , Diagnosis And Treatment , Western Europe , Globe Newswire , Medical Biotechnology Industry ,